Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 9:16 pm Purchase | 2026-06-30 | 13G | TRAWS PHARMA, INC PAR TRAW | Ikarian Capital, LLC | 1,555,423 9.500% | 742,899 (+91.43%) | Filing History |
| 2026-08-14 1:24 pm Sale | 2026-06-30 | 13G | TRAWS PHARMA, INC PAR TRAW | Squadron Capital Management LLC | 0 0.000% | -511,714 (Position Closed) | Filing History |
| 2026-08-14 08:36 am Purchase | 2026-06-30 | 13G | TRAWS PHARMA, INC PAR TRAW | Sirenia Capital Management LP | 6,565,474 9.900% | 6,565,474 (New Position) | Filing History |
| 2026-08-12 12:00 pm Unchanged | 2026-06-30 | 13G | TRAWS PHARMA, INC PAR TRAW | Adage Capital Management, L.P. | 730,000 4.790% | 0 (Unchanged) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Perceptive Advisors LLC | 979,815 6.100% | 92,928 (+10.48%) | Filing History |
| 2026-05-15 11:50 am Sale | 2026-03-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Squadron Capital Management LLC | 511,714 6.400% | -201,826 (-28.29%) | Filing History |
| 2026-05-05 6:55 pm Purchase | 2026-04-16 | 13D | TRAWS PHARMA, INC PAR TRAW | ORBIMED ADVISORS LLC | 1,876,198 11.900% | 1,115,374 (+146.60%) | Filing History |
| 2026-02-17 5:11 pm Purchase | 2025-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Ikarian Capital, LLC | 812,524 9.990% | 223,022 (+37.83%) | Filing History |
| 2026-02-17 12:36 pm Purchase | 2025-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Squadron Capital Management LLC | 713,540 8.900% | 122,540 (+20.73%) | Filing History |
| 2026-02-12 09:11 am Purchase | 2025-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Adage Capital Management, L.P. | 730,000 9.140% | 400,000 (+121.21%) | Filing History |
| 2026-02-11 09:44 am Sale | 2025-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Ayrton Capital LLC | 342,935 4.290% | -60,715 (-15.04%) | Filing History |
| 2026-01-16 4:47 pm Purchase | 2026-01-14 | 13G | TRAWS PHARMA, INC PAR TRAW | Chernett Jorey | 543,268 6.800% | 543,268 (New Position) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | TRAWS PHARMA, INC PAR TRAW | Perceptive Advisors LLC | 886,887 9.990% | 341,690 (+62.67%) | Filing History |
| 2025-11-14 2:29 pm Purchase | 2025-09-30 | 13G | TRAWS PHARMA, INC PAR TRAW | Squadron Capital Management LLC | 591,000 8.400% | 170,499 (+40.55%) | Filing History |
| 2025-11-13 09:07 am Unchanged | 2025-09-30 | 13G | TRAWS PHARMA, INC PAR TRAW | Adage Capital Management, L.P. | 330,000 4.670% | 0 (Unchanged) | Filing History |
| 2025-09-19 3:04 pm Purchase | 2025-09-12 | 13G | TRAWS PHARMA, INC PAR TRAW | Squadron Capital Management LLC | 420,501 6.000% | 420,501 (New Position) | Filing History |
| 2025-05-15 5:26 pm Purchase | 2025-03-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Ikarian Capital, LLC | 589,502 9.990% | 195,247 (+49.52%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Perceptive Advisors LLC | 545,197 9.990% | 158,642 (+41.04%) | Filing History |
| 2025-05-12 09:02 am Purchase | 2025-03-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Adage Capital Management, L.P. | 330,000 6.500% | 330,000 (New Position) | Filing History |
| 2025-02-14 4:22 pm Purchase | 2024-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Alyeska Investment Group, L.P. | 302,252 9.900% | 302,252 (New Position) | Filing History |